Inspire Medical Systems, Inc. Q3 2025 Earnings Recap

INSP Q3 2025 November 6, 2025

Inspire Medical Systems delivered robust third-quarter results, with revenue rising 10% year-over-year to $224.5 million, supported by strong patient adoption and favorable reimbursement developments.

Earnings Per Share Beat

$0.38 vs $-0.15 est.

+353.3% surprise

Revenue Miss

224501000 vs 262300330 est.

-14.4% surprise

Market Reaction

1-Day +1.2%

5-Day +9.38%

30-Day +52.55%

Key Takeaways

Operating income reached $9.6 million, with earnings per share guidance upgraded to $0.90–$1.00, reflecting improved cost discipline and revenue growth.
Physician training for the Inspire V system is over 98% complete, and contracting is over 90% finalized, positioning the company for a successful product launch.
Recent clinical studies highlighted Inspire’s effectiveness in reducing long-term cardiovascular risks in OSA patients, reinforcing the company's commitment to innovation and patient outcomes.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit INSP on AllInvestView.